Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis

INTRODUCTION: Extraintestinal manifestations (EIMs) in patients with ulcerative colitis (UC) are common. Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of UC. We evaluated the efficacy of tofacitinib in patients with EIMs, and the impact of tofacitinib on EIMs in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, David T., Reinisch, Walter, Greuter, Thomas, Kotze, Paulo G., Pinheiro, Marcia, Mundayat, Rajiv, Maller, Eric, Fellmann, Marc, Lawendy, Nervin, Modesto, Irene, Vavricka, Stephan R., Lichtenstein, Gary R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132089/
https://www.ncbi.nlm.nih.gov/pubmed/34035832
http://dx.doi.org/10.1177/17562848211005708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132089/
https://www.ncbi.nlm.nih.gov/pubmed/34035832
http://dx.doi.org/10.1177/17562848211005708

Ejemplares similares